Global Antiemetics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: November 2022

No. of Pages: 101

Price:

Single User License: US $ 5600

Corporate User License: US $ 11200

Report Description
Table of Contents

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiemetics manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antiemetics market. Further, it explains the major drivers and regional dynamics of the global Antiemetics market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- GlaxoSmithKline
- Merck
- Sanofi Aventis
- Bristol Myers Squibb
- Eli Lilly
- Pfizer
- Astellas
- Johnson & Johnson
- Baxter

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Antiemetics Segment by Type
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- Others
Antiemetics Segment by Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antiemetics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Antiemetics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antiemetics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antiemetics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiemetics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antiemetics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antiemetics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson and Baxter, etc.

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antiemetics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 5-HT3 receptor antagonists
1.2.3 Dopamine antagonists
1.2.4 NK1 receptor antagonist
1.2.5 Antihistamines (H1 histamine receptor antagonists)
1.2.6 Cannabinoids
1.2.7 Benzodiazepines
1.2.8 Anticholinergics
1.2.9 Steroids
1.2.10 Others
1.3 Market Segment by Application
1.3.1 Global Antiemetics Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antiemetics Market Size (2017-2028)
2.1.1 Global Antiemetics Revenue (2017-2028)
2.1.2 Global Antiemetics Sales (2017-2028)
2.2 Global Antiemetics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Antiemetics Sales by Regions (2017-2022)
2.2.2 Global Antiemetics Revenue by Regions (2017-2022)
2.3 Global Antiemetics Market Size Forecast by Region
2.3.1 Global Antiemetics Sales Forecast by Region (2023-2028)
2.3.2 Global Antiemetics Revenue Forecast by Region (2023-2028)
2.4 Global Top Antiemetics Regions (Countries) Ranking by Market Size
2.5 Antiemetics Market Dynamics
2.5.1 Antiemetics Market Trends
2.5.2 Antiemetics Market Drivers
2.5.3 Antiemetics Market Challenges
2.5.4 Antiemetics Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Antiemetics Manufacturers by Sales (2017-2022)
3.1.1 Global Antiemetics Sales by Manufacturers (2017-2022)
3.1.2 Global Antiemetics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Antiemetics Sales in 2021
3.2 Global Top Manufacturers Antiemetics by Revenue
3.2.1 Global Antiemetics Revenue by Manufacturers (2017-2022)
3.2.2 Top Antiemetics Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antiemetics Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Antiemetics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetics as of 2021)
3.4 Global Antiemetics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antiemetics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antiemetics Market
3.7 Key Manufacturers Antiemetics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antiemetics Market Size by Type
4.1 Global Antiemetics Historic Market Review by Type (2017-2022)
4.1.1 Global Antiemetics Sales Market Share by Type (2017-2022)
4.1.2 Global Antiemetics Revenue Market Share by Type (2017-2022)
4.1.3 Antiemetics Price by Type (2017-2022)
4.2 Global Antiemetics Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Antiemetics Sales Forecast by Type (2023-2028)
4.2.2 Global Antiemetics Revenue Forecast by Type (2023-2028)
4.2.3 Antiemetics Price Forecast by Type (2023-2028)
5 Global Antiemetics Market Size by Application
5.1 Global Antiemetics Historic Market Review by Application (2017-2022)
5.1.1 Global Antiemetics Sales Market Share by Application (2017-2022)
5.1.2 Global Antiemetics Revenue Market Share by Application (2017-2022)
5.1.3 Antiemetics Price by Application (2017-2022)
5.2 Global Antiemetics Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Antiemetics Sales Forecast by Application (2023-2028)
5.2.2 Global Antiemetics Revenue Forecast by Application (2023-2028)
5.2.3 Antiemetics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antiemetics Sales Breakdown by Company
6.1.1 North America Antiemetics Sales by Company (2017-2022)
6.1.2 North America Antiemetics Revenue by Company (2017-2022)
6.2 North America Antiemetics Market Size by Type
6.2.1 North America Antiemetics Sales by Type (2017-2028)
6.2.2 North America Antiemetics Revenue by Type (2017-2028)
6.3 North America Antiemetics Market Size by Application
6.3.1 North America Antiemetics Sales by Application (2017-2028)
6.3.2 North America Antiemetics Revenue by Application (2017-2028)
6.4 North America Antiemetics Market Size by Country
6.4.1 North America Antiemetics Sales by Country (2017-2028)
6.4.2 North America Antiemetics Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antiemetics Sales Breakdown by Company
7.1.1 Europe Antiemetics Sales by Company (2017-2022)
7.1.2 Europe Antiemetics Revenue by Company (2017-2022)
7.2 Europe Antiemetics Market Size by Type
7.2.1 Europe Antiemetics Sales by Type (2017-2028)
7.2.2 Europe Antiemetics Revenue by Type (2017-2028)
7.3 Europe Antiemetics Market Size by Application
7.3.1 Europe Antiemetics Sales by Application (2017-2028)
7.3.2 Europe Antiemetics Revenue by Application (2017-2028)
7.4 Europe Antiemetics Market Size by Country
7.4.1 Europe Antiemetics Sales by Country (2017-2028)
7.4.2 Europe Antiemetics Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antiemetics Sales Breakdown by Company
8.1.1 Asia Pacific Antiemetics Sales by Company (2017-2022)
8.1.2 Asia Pacific Antiemetics Revenue by Company (2017-2022)
8.2 Asia Pacific Antiemetics Market Size by Type
8.2.1 Asia Pacific Antiemetics Sales by Type (2017-2028)
8.2.2 Asia Pacific Antiemetics Revenue by Type (2017-2028)
8.3 Asia Pacific Antiemetics Market Size by Application
8.3.1 Asia Pacific Antiemetics Sales by Application (2017-2028)
8.3.2 Asia Pacific Antiemetics Revenue by Application (2017-2028)
8.4 Asia Pacific Antiemetics Market Size by Region
8.4.1 Asia Pacific Antiemetics Sales by Region
8.4.2 Asia Pacific Antiemetics Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Antiemetics Sales Breakdown by Company
9.1.1 Latin America Antiemetics Sales by Company (2017-2022)
9.1.2 Latin America Antiemetics Revenue by Company (2017-2022)
9.2 Latin America Antiemetics Market Size by Type
9.2.1 Latin America Antiemetics Sales by Type (2017-2028)
9.2.2 Latin America Antiemetics Revenue by Type (2017-2028)
9.3 Latin America Antiemetics Market Size by Application
9.3.1 Latin America Antiemetics Sales by Application (2017-2028)
9.3.2 Latin America Antiemetics Revenue by Application (2017-2028)
9.4 Latin America Antiemetics Market Size by Country
9.4.1 Latin America Antiemetics Sales by Country (2017-2028)
9.4.2 Latin America Antiemetics Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiemetics Sales Breakdown by Company
10.1.1 Middle East and Africa Antiemetics Sales by Company (2017-2022)
10.1.2 Middle East and Africa Antiemetics Revenue by Company (2017-2022)
10.2 Middle East and Africa Antiemetics Market Size by Type
10.2.1 Middle East and Africa Antiemetics Sales by Type (2017-2028)
10.2.2 Middle East and Africa Antiemetics Revenue by Type (2017-2028)
10.3 Middle East and Africa Antiemetics Market Size by Application
10.3.1 Middle East and Africa Antiemetics Sales by Application (2017-2028)
10.3.2 Middle East and Africa Antiemetics Revenue by Application (2017-2028)
10.4 Middle East and Africa Antiemetics Market Size by Country
10.4.1 Middle East and Africa Antiemetics Sales by Country (2017-2028)
10.4.2 Middle East and Africa Antiemetics Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Antiemetics Products and Services
11.1.5 GlaxoSmithKline Antiemetics SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Antiemetics Products and Services
11.2.5 Merck Antiemetics SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Corporation Information
11.3.2 Sanofi Aventis Overview
11.3.3 Sanofi Aventis Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sanofi Aventis Antiemetics Products and Services
11.3.5 Sanofi Aventis Antiemetics SWOT Analysis
11.3.6 Sanofi Aventis Recent Developments
11.4 Bristol Myers Squibb
11.4.1 Bristol Myers Squibb Corporation Information
11.4.2 Bristol Myers Squibb Overview
11.4.3 Bristol Myers Squibb Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Bristol Myers Squibb Antiemetics Products and Services
11.4.5 Bristol Myers Squibb Antiemetics SWOT Analysis
11.4.6 Bristol Myers Squibb Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Eli Lilly Antiemetics Products and Services
11.5.5 Eli Lilly Antiemetics SWOT Analysis
11.5.6 Eli Lilly Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Pfizer Antiemetics Products and Services
11.6.5 Pfizer Antiemetics SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Astellas
11.7.1 Astellas Corporation Information
11.7.2 Astellas Overview
11.7.3 Astellas Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Astellas Antiemetics Products and Services
11.7.5 Astellas Antiemetics SWOT Analysis
11.7.6 Astellas Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Antiemetics Products and Services
11.8.5 Johnson & Johnson Antiemetics SWOT Analysis
11.8.6 Johnson & Johnson Recent Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Overview
11.9.3 Baxter Antiemetics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Baxter Antiemetics Products and Services
11.9.5 Baxter Antiemetics SWOT Analysis
11.9.6 Baxter Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antiemetics Value Chain Analysis
12.2 Antiemetics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiemetics Production Mode & Process
12.4 Antiemetics Sales and Marketing
12.4.1 Antiemetics Sales Channels
12.4.2 Antiemetics Distributors
12.5 Antiemetics Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Antiemetics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 5-HT3 receptor antagonists
Table 3. Major Manufacturers of Dopamine antagonists
Table 4. Major Manufacturers of NK1 receptor antagonist
Table 5. Major Manufacturers of Antihistamines (H1 histamine receptor antagonists)
Table 6. Major Manufacturers of Cannabinoids
Table 7. Major Manufacturers of Benzodiazepines
Table 8. Major Manufacturers of Anticholinergics
Table 9. Major Manufacturers of Steroids
Table 10. Major Manufacturers of Others
Table 11. Global Antiemetics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Antiemetics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 13. Global Antiemetics Sales by Region (2017-2022) & (K Units)
Table 14. Global Antiemetics Sales Market Share by Region (2017-2022)
Table 15. Global Antiemetics Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Antiemetics Revenue Market Share by Region (2017-2022)
Table 17. Global Antiemetics Sales Forecast by Region (2023-2028) & (K Units)
Table 18. Global Antiemetics Sales Market Share Forecast by Region (2023-2028)
Table 19. Global Antiemetics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 20. Global Antiemetics Revenue Market Share Forecast by Region (2023-2028)
Table 21. Top Antiemetics Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 22. Antiemetics Market Trends
Table 23. Antiemetics Market Drivers
Table 24. Antiemetics Market Challenges
Table 25. Antiemetics Market Restraints
Table 26. Global Antiemetics Sales by Manufacturers (2017-2022) & (K Units)
Table 27. Global Antiemetics Sales Share by Manufacturers (2017-2022)
Table 28. Global Antiemetics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 29. Ranking of Global Top Antiemetics Manufacturers by Revenue (US$ Million) in 2021
Table 30. Antiemetics Revenue Share by Manufacturers (2017-2022)
Table 31. Global Antiemetics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetics as of 2021)
Table 33. Key Manufacturers Antiemetics Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 34. Key Manufacturers Antiemetics Plants/Factories Distribution
Table 35. Key Manufacturers Antiemetics Area Served
Table 36. Date of Key Manufacturers Enter into Antiemetics Market
Table 37. Key Manufacturers Antiemetics Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Antiemetics Sales (K Units) by Type (2017-2022)
Table 40. Global Antiemetics Sales Share by Type (2017-2022)
Table 41. Global Antiemetics Revenue (US$ Million) Market Share by Type (2017-2022)
Table 42. Global Antiemetics Price (K Units) by Type (2017-2022)
Table 43. Global Antiemetics Sales (K Units) by Type (2023-2028)
Table 44. Global Antiemetics Sales Share by Type (2023-2028)
Table 45. Global Antiemetics Revenue (US$ Million) Market Share by Type (2023-2028)
Table 46. Global Antiemetics Revenue Share by Type (2023-2028)
Table 47. Global Antiemetics Price (K Units) by Type (2023-2028)
Table 48. Global Antiemetics Sales (K Units) by Application (2017-2022)
Table 49. Global Antiemetics Sales Share by Application (2017-2022)
Table 50. Global Antiemetics Revenue (US$ Million) Market Share by Application (2017-2022)
Table 51. Global Antiemetics Price (K Units) by Application (2017-2022)
Table 52. Global Antiemetics Sales (K Units) by Application (2023-2028)
Table 53. Global Antiemetics Sales Share by Application (2023-2028)
Table 54. Global Antiemetics Revenue (US$ Million) Market Share by Application (2023-2028)
Table 55. Global Antiemetics Revenue Share by Application (2023-2028)
Table 56. Global Antiemetics Price (K Units) by Application (2023-2028)
Table 57. North America Antiemetics Sales by Company (2017-2022) & (K Units)
Table 58. North America Antiemetics Sales Market Share by Company (2017-2022)
Table 59. North America Antiemetics Revenue by Company (2017-2022) & (US$ Million)
Table 60. North America Antiemetics Revenue Market Share by Company (2017-2022)
Table 61. North America Antiemetics Sales by Type (2017-2022) & (K Units)
Table 62. North America Antiemetics Sales by Type (2023-2028) & (K Units)
Table 63. North America Antiemetics Revenue by Type (2017-2022) & (US$ Million)
Table 64. North America Antiemetics Revenue by Type (2023-2028) & (US$ Million)
Table 65. North America Antiemetics Sales by Application (2017-2022) & (K Units)
Table 66. North America Antiemetics Sales by Application (2023-2028) & (K Units)
Table 67. North America Antiemetics Revenue by Application (2017-2022) & (US$ Million)
Table 68. North America Antiemetics Revenue by Application (2023-2028) & (US$ Million)
Table 69. North America Antiemetics Sales by Country (2017-2022) & (K Units)
Table 70. North America Antiemetics Sales by Country (2023-2028) & (K Units)
Table 71. North America Antiemetics Revenue by Country (2017-2022) & (US$ Million)
Table 72. North America Antiemetics Revenue by Country (2023-2028) & (US$ Million)
Table 73. Europe Antiemetics Sales by Company (2017-2022) & (K Units)
Table 74. Europe Antiemetics Sales Market Share by Company (2017-2022)
Table 75. Europe Antiemetics Revenue by Company (2017-2022) & (US$ Million)
Table 76. Europe Antiemetics Revenue Market Share by Company (2017-2022)
Table 77. Europe Antiemetics Sales by Type (2017-2022) & (K Units)
Table 78. Europe Antiemetics Sales by Type (2023-2028) & (K Units)
Table 79. Europe Antiemetics Revenue by Type (2017-2022) & (US$ Million)
Table 80. Europe Antiemetics Revenue by Type (2023-2028) & (US$ Million)
Table 81. Europe Antiemetics Sales by Application (2017-2022) & (K Units)
Table 82. Europe Antiemetics Sales by Application (2023-2028) & (K Units)
Table 83. Europe Antiemetics Revenue by Application (2017-2022) & (US$ Million)
Table 84. Europe Antiemetics Revenue by Application (2023-2028) & (US$ Million)
Table 85. Europe Antiemetics Sales by Country (2017-2022) & (K Units)
Table 86. Europe Antiemetics Sales by Country (2023-2028) & (K Units)
Table 87. Europe Antiemetics Revenue by Country (2017-2022) & (US$ Million)
Table 88. Europe Antiemetics Revenue by Country (2023-2028) & (US$ Million)
Table 89. Asia Pacific Antiemetics Sales by Company (2017-2022) & (K Units)
Table 90. Asia Pacific Antiemetics Sales Market Share by Company (2017-2022)
Table 91. Asia Pacific Antiemetics Revenue by Company (2017-2022) & (US$ Million)
Table 92. Asia Pacific Antiemetics Revenue Market Share by Company (2017-2022)
Table 93. Asia Pacific Antiemetics Sales by Type (2017-2022) & (K Units)
Table 94. Asia Pacific Antiemetics Sales by Type (2023-2028) & (K Units)
Table 95. Asia Pacific Antiemetics Revenue by Type (2017-2022) & (US$ Million)
Table 96. Asia Pacific Antiemetics Revenue by Type (2023-2028) & (US$ Million)
Table 97. Asia Pacific Antiemetics Sales by Application (2017-2022) & (K Units)
Table 98. Asia Pacific Antiemetics Sales by Application (2023-2028) & (K Units)
Table 99. Asia Pacific Antiemetics Revenue by Application (2017-2022) & (US$ Million)
Table 100. Asia Pacific Antiemetics Revenue by Application (2023-2028) & (US$ Million)
Table 101. Asia Pacific Antiemetics Sales by Region (2017-2022) & (K Units)
Table 102. Asia Pacific Antiemetics Sales by Region (2023-2028) & (K Units)
Table 103. Asia Pacific Antiemetics Revenue by Region (2017-2022) & (US$ Million)
Table 104. Asia Pacific Antiemetics Revenue by Region (2023-2028) & (US$ Million)
Table 105. Latin America Antiemetics Sales by Company (2017-2022) & (K Units)
Table 106. Latin America Antiemetics Sales Market Share by Company (2017-2022)
Table 107. Latin America Antiemetics Revenue by Company (2017-2022) & (US$ Million)
Table 108. Latin America Antiemetics Revenue Market Share by Company (2017-2022)
Table 109. Latin America Antiemetics Sales by Type (2017-2022) & (K Units)
Table 110. Latin America Antiemetics Sales by Type (2023-2028) & (K Units)
Table 111. Latin America Antiemetics Revenue by Type (2017-2022) & (US$ Million)
Table 112. Latin America Antiemetics Revenue by Type (2023-2028) & (US$ Million)
Table 113. Latin America Antiemetics Sales by Application (2017-2022) & (K Units)
Table 114. Latin America Antiemetics Sales by Application (2023-2028) & (K Units)
Table 115. Latin America Antiemetics Revenue by Application (2017-2022) & (US$ Million)
Table 116. Latin America Antiemetics Revenue by Application (2023-2028) & (US$ Million)
Table 117. Latin America Antiemetics Sales by Country (2017-2022) & (K Units)
Table 118. Latin America Antiemetics Sales by Country (2023-2028) & (K Units)
Table 119. Latin America Antiemetics Revenue by Country (2017-2022) & (US$ Million)
Table 120. Latin America Antiemetics Revenue by Country (2023-2028) & (US$ Million)
Table 121. Middle East and Africa Antiemetics Sales by Company (2017-2022) & (K Units)
Table 122. Middle East and Africa Antiemetics Sales Market Share by Company (2017-2022)
Table 123. Middle East and Africa Antiemetics Revenue by Company (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Antiemetics Revenue Market Share by Company (2017-2022)
Table 125. Middle East and Africa Antiemetics Sales by Type (2017-2022) & (K Units)
Table 126. Middle East and Africa Antiemetics Sales by Type (2023-2028) & (K Units)
Table 127. Middle East and Africa Antiemetics Revenue by Type (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Antiemetics Revenue by Type (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Antiemetics Sales by Application (2017-2022) & (K Units)
Table 130. Middle East and Africa Antiemetics Sales by Application (2023-2028) & (K Units)
Table 131. Middle East and Africa Antiemetics Revenue by Application (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Antiemetics Revenue by Application (2023-2028) & (US$ Million)
Table 133. Middle East and Africa Antiemetics Sales by Country (2017-2022) & (K Units)
Table 134. Middle East and Africa Antiemetics Sales by Country (2023-2028) & (K Units)
Table 135. Middle East and Africa Antiemetics Revenue by Country (2017-2022) & (US$ Million)
Table 136. Middle East and Africa Antiemetics Revenue by Country (2023-2028) & (US$ Million)
Table 137. GlaxoSmithKline Corporation Information
Table 138. GlaxoSmithKline Description and Overview
Table 139. GlaxoSmithKline Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. GlaxoSmithKline Antiemetics Product and Services
Table 141. GlaxoSmithKline Antiemetics SWOT Analysis
Table 142. GlaxoSmithKline Recent Developments
Table 143. Merck Corporation Information
Table 144. Merck Description and Overview
Table 145. Merck Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Merck Antiemetics Product and Services
Table 147. Merck Antiemetics SWOT Analysis
Table 148. Merck Recent Developments
Table 149. Sanofi Aventis Corporation Information
Table 150. Sanofi Aventis Description and Overview
Table 151. Sanofi Aventis Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Sanofi Aventis Antiemetics Product and Services
Table 153. Sanofi Aventis Antiemetics SWOT Analysis
Table 154. Sanofi Aventis Recent Developments
Table 155. Bristol Myers Squibb Corporation Information
Table 156. Bristol Myers Squibb Description and Overview
Table 157. Bristol Myers Squibb Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Bristol Myers Squibb Antiemetics Product and Services
Table 159. Bristol Myers Squibb Antiemetics SWOT Analysis
Table 160. Bristol Myers Squibb Recent Developments
Table 161. Eli Lilly Corporation Information
Table 162. Eli Lilly Description and Overview
Table 163. Eli Lilly Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Eli Lilly Antiemetics Product and Services
Table 165. Eli Lilly Antiemetics SWOT Analysis
Table 166. Eli Lilly Recent Developments
Table 167. Pfizer Corporation Information
Table 168. Pfizer Description and Overview
Table 169. Pfizer Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Pfizer Antiemetics Product and Services
Table 171. Pfizer Antiemetics SWOT Analysis
Table 172. Pfizer Recent Developments
Table 173. Astellas Corporation Information
Table 174. Astellas Description and Overview
Table 175. Astellas Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Astellas Antiemetics Product and Services
Table 177. Astellas Antiemetics SWOT Analysis
Table 178. Astellas Recent Developments
Table 179. Johnson & Johnson Corporation Information
Table 180. Johnson & Johnson Description and Overview
Table 181. Johnson & Johnson Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 182. Johnson & Johnson Antiemetics Product and Services
Table 183. Johnson & Johnson Antiemetics SWOT Analysis
Table 184. Johnson & Johnson Recent Developments
Table 185. Baxter Corporation Information
Table 186. Baxter Description and Overview
Table 187. Baxter Antiemetics Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 188. Baxter Antiemetics Product and Services
Table 189. Baxter Antiemetics SWOT Analysis
Table 190. Baxter Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Antiemetics Distributors List
Table 194. Antiemetics Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiemetics Product Picture
Figure 2. Global Antiemetics Sales Market Share by Type in 2021 & 2028
Figure 3. 5-HT3 receptor antagonists Product Picture
Figure 4. Dopamine antagonists Product Picture
Figure 5. NK1 receptor antagonist Product Picture
Figure 6. Antihistamines (H1 histamine receptor antagonists) Product Picture
Figure 7. Cannabinoids Product Picture
Figure 8. Benzodiazepines Product Picture
Figure 9. Anticholinergics Product Picture
Figure 10. Steroids Product Picture
Figure 11. Others Product Picture
Figure 12. Global Antiemetics Sales Market Share by Application in 2021 & 2028
Figure 13. Hospital Pharmacy Use Case
Figure 14. Retail Pharmacy Use Case
Figure 15. Online Pharmacy Use Case
Figure 16. Others Use Case
Figure 17. Antiemetics Report Years Considered
Figure 18. Global Antiemetics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Antiemetics Market Size 2017-2028 (US$ Million)
Figure 20. Global Antiemetics Sales (2017-2022) & (K Units)
Figure 21. Global Antiemetics Market Size Market Share by Region: 2021 VS 2028
Figure 22. Global Antiemetics Sales Market Share by Region (2017-2022)
Figure 23. Global Antiemetics Sales Market Share by Region in 2021
Figure 24. Global Antiemetics Revenue Market Share by Region in 2017 VS 2021
Figure 25. Global Antiemetics Sales Share by Manufacturers in 2021
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiemetics Sales in 2021
Figure 27. Antiemetics Revenue Share by Manufacturers in 2021
Figure 28. Antiemetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 29. Global Antiemetics Revenue Share by Type (2017-2022)
Figure 30. Global Antiemetics Revenue Growth Rate by Type in 2017 & 2021
Figure 31. Global Antiemetics Revenue Share by Application (2017-2022)
Figure 32. Global Antiemetics Revenue Growth Rate by Application in 2017 & 2021
Figure 33. North America Antiemetics Sales Market Share by Type (2017-2028)
Figure 34. North America Antiemetics Revenue Market Share by Type (2017-2028)
Figure 35. North America Antiemetics Sales Market Share by Application (2017-2028)
Figure 36. North America Antiemetics Revenue Market Share by Application (2017-2028)
Figure 37. North America Antiemetics Sales Share by Country (2017-2028)
Figure 38. North America Antiemetics Revenue Share by Country (2017-2028)
Figure 39. U.S. Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Antiemetics Sales Market Share by Type (2017-2028)
Figure 42. Europe Antiemetics Revenue Market Share by Type (2017-2028)
Figure 43. Europe Antiemetics Sales Market Share by Application (2017-2028)
Figure 44. Europe Antiemetics Revenue Market Share by Application (2017-2028)
Figure 45. Europe Antiemetics Sales Share by Country (2017-2028)
Figure 46. Europe Antiemetics Revenue Share by Country (2017-2028)
Figure 47. Germany Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 48. France Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Antiemetics Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Antiemetics Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Antiemetics Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Antiemetics Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Antiemetics Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Antiemetics Revenue Share by Region (2017-2028)
Figure 58. China Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 61. India Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Antiemetics Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Antiemetics R

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group2076150

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *